Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market - New report by MarketsandMarkets™

The overall market for breast lesion localization methods is projected to reach $877.9 million by 2020 from $445.9 million in 2015, at a CAGR of 14.5% from 2015 to 2020. Breast lesion localization methods is a pre-surgical procedure where localization devices such as, magnetic tracer, radioisotopes, wires are used to insert into the cancer detected site to localize a non-palpable lesion at the time of surgical excision.

The selection of the appropriate localization method for end users (healthcare providers) is a very crucial decision, and is dependent on a number of factors, such as detection and success rate, re-excision rate, cost, mean localization time, effectiveness, safety, ease of use, and mean operating time, among other parameters. The importance of these parameters differs according to the diagnostic requirements of various end users.

Detection and success rate, mean localization time, and re-excision rate are perceived to be relatively more important selection criteria by healthcare providers. This is because new localization methods are technologically advanced and offer better features, which have the potential to help healthcare providers deliver improved treatments. However, as a result of budgetary constraints among end users, the cost of localization methods is indicated as one of the most significant criteria for the selection of these instruments.

According to the replacement trends studied in all geographies, wire localization is an established technique for preoperative localization of breast lesions; most respondents are using this technique and are willing to continue with it in the future. However, nearly 40% of healthcare providers are willing to shift towards technologically advanced options such as RSL and magnetic tracers.

Some of the key players in the breast lesion localization methods market are C.R. Bard (U.S.), Ranfac Corporation (U.S.), Invivo Corporation (U.S.), SOMATEX Medical Technologies GmbH (Germany), Argon Medical Devices (U.S.), SurgicEye GmbH (Germany), GE Healthcare (U.K.), Intra-Medical Imaging LLC (U.S.), IsoAid, LLC (U.S.), NuclearLab S.R.L. (Argentina), Cianna Medical (U.S.), Endomagnetics Ltd. (U.K.), and Cook Medical (U.S.), among others.

The key strategies adopted by most companies in breast lesion localization methods market include new product launches and licensing; agreements, collaborations, and partnerships; and expansion. For instance, in October 2014, IntraMedical Imaging LLC (U.S.) exclusively licensed a patent from the University of South Florida for the use of radioactive localization seeds in breast lesion localization. Similarly, in January 2012, Endomagnetics Ltd. (U.K.) launched Sentimag and Sienna plus, which offers magnetic tracer localization, in the U.K.

Related Reports:

Breast Lesion Localization Methods Market - Comparative Analysis, Field Force Analysis, Business Models, End User Preference Survey (Selection Criteria, Qualitative Analysis of Replacement Trend), Competitive Product Portfolio and Strategic Consolidation

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com

Report Code
MD 4236
Published ON
Apr, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Breast Lesion Localization Methods Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved